Clinical Trial Update: A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study

View source ↗

Summary

Long-term follow-up results from participants who completed the PEP005-020 trial evaluating ingenol mebutate for actinic keratosis are reported. The update summ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• PEP005 / ingenol mebutate (ingenol mebutate)

Snippet

Sponsor: Peplin | Conditions: Actinic Keratosis | Status: COMPLETED